Pharmaceutical
-
{
- All
- News
- Videos
-
Weight-Loss Injections Under Scrutiny: American Body Flags Contamination At Chinese GLP-1 Drug Plants
The FDA's actions against Chengdu Shengnuo Biopharm and Nanjing Chengong Pharmaceutical underscore the importance of sanitation, reliable documentation, supplier verification and quality-control systems in pharmaceutical manufacturing.
-
Princeton PhD To Crab Cake Applications: 30-Year-Old Applies For Over 2,300 Jobs, Still Seeks Stable Employment
The summer saw long-term US unemployment, approx. 27 weeks, hit a near-decade high, excluding the pandemic and its aftermath, according to the report.
-
Supreme Court Directs Centre To Form Panel To Curb 'Unethical' Pharma Marketing Practices; Freebies To Doctors
The case has been pending before the top court for several years and has repeatedly drawn judicial scrutiny of the pharmaceutical industry's promotional practices.
-
5 Killed, 10 Injured In Boiler Explosion At Pharma Firm In Andhra
The explosion in the TIL Healthcare pharmaceutical firm in Sri City caused panic, following which rescue and emergency teams rushed to the spot.
-
Karnataka Flags Wide Disparity Between Landing Cost And MRP Of High-Cost Drugs And Medical Consumables, Seeks Central Government Intervention
Recent investigations by the Karnataka Food Safety and Drug Administration (FDA) have revealed that pharmaceutical companies are supplying medicines to hospitals at heavily discounted institutional (landing) prices, while patients are being billed at or near the printed MRP.
-
US Waives Percentage Tax On Rare Disease, Speciality Drugs Imported From India
The move is part of the US administration's wider changes to pharmaceutical imports under Section 232 of the Trade Expansion Act. A zero tariff means eligible medicines from India will not face an additional percentage-based import duty.
-
US Waives Tariffs On Specialty Drugs From India, 19 Other Countries
The exemptions are part of the implementation of Trump's April proclamation adjusting imports of pharmaceuticals and pharmaceutical ingredients under Section 232 of the Trade Expansion Act.
-
India's Pharma Market Expands 10.7% On GLP-1 Launch: Zydus, Glenmark Lead Large-Cap Growth
A majority of companies within Nomura's coverage universe outpaced the broader pharma market in August. Zydus Lifesciences and Glenmark Pharmaceuticals posted the strongest YoY value expansion.
-
Karnataka To Discuss New Guidelines On Online Medicine Sales, Pricing
Karnataka Health and Family Welfare Minister U.T. Khader on Monday said the state government was adopting a two-pronged approach to strengthen inspections and enforcement in the food and pharmaceutical sectors, amid complaints regarding expired medicines, mislabelling, and exorbitant prices.
-
Fake, Expired Medicines Worth Rs 5 Crore Seized Repacking Unit In Bengaluru
According to the FDA, the operators were procuring lower-cost medicines from other states and allegedly filling them into new vials before relabelling them to resemble expensive multinational and imported drug brands.
-
Eli Lilly Shares Surge 6% On Upbeat Annual Earnings Forecast; Mounjaro Sales Spike 91%
Due to expenses associated with commercial activity during the quarter, Lilly reduced the upper end of its full-year profit expectation.
-
New HIV Pill Delivers Breakthrough Results In First Human Trial
Researchers say the treatment appears safe and effective so far, although larger Phase 3 trials will be needed before it can be approved for widespread use.
-
Glenmark Pharma Q1 Results: Profit Rises Exponentially To Rs 483 Crore; Revenue Jumps 23%
Glenmark Pharmaceuticals reported a consolidated net profit of Rs 483 crore, compared with Rs 47 crore in the corresponding quarter last year.
-
One QR Scan Can Tell If Your Medicine Is Fake. Here's How It Works
The government has steadily expanded the use of QR codes to make fake medicines harder to introduce into the supply chain.
-
US Turn To Indian Pharmaceuticals Amid Critical Cancer Drug Shortage
US has sought help from Indian pharmaceutical manufacturers to address a shortage of the cancer drug ifosfamide.
-
Weight-Loss Injections Under Scrutiny: American Body Flags Contamination At Chinese GLP-1 Drug Plants
The FDA's actions against Chengdu Shengnuo Biopharm and Nanjing Chengong Pharmaceutical underscore the importance of sanitation, reliable documentation, supplier verification and quality-control systems in pharmaceutical manufacturing.
-
Princeton PhD To Crab Cake Applications: 30-Year-Old Applies For Over 2,300 Jobs, Still Seeks Stable Employment
The summer saw long-term US unemployment, approx. 27 weeks, hit a near-decade high, excluding the pandemic and its aftermath, according to the report.
-
Supreme Court Directs Centre To Form Panel To Curb 'Unethical' Pharma Marketing Practices; Freebies To Doctors
The case has been pending before the top court for several years and has repeatedly drawn judicial scrutiny of the pharmaceutical industry's promotional practices.
-
5 Killed, 10 Injured In Boiler Explosion At Pharma Firm In Andhra
The explosion in the TIL Healthcare pharmaceutical firm in Sri City caused panic, following which rescue and emergency teams rushed to the spot.
-
Karnataka Flags Wide Disparity Between Landing Cost And MRP Of High-Cost Drugs And Medical Consumables, Seeks Central Government Intervention
Recent investigations by the Karnataka Food Safety and Drug Administration (FDA) have revealed that pharmaceutical companies are supplying medicines to hospitals at heavily discounted institutional (landing) prices, while patients are being billed at or near the printed MRP.
-
US Waives Percentage Tax On Rare Disease, Speciality Drugs Imported From India
The move is part of the US administration's wider changes to pharmaceutical imports under Section 232 of the Trade Expansion Act. A zero tariff means eligible medicines from India will not face an additional percentage-based import duty.
-
US Waives Tariffs On Specialty Drugs From India, 19 Other Countries
The exemptions are part of the implementation of Trump's April proclamation adjusting imports of pharmaceuticals and pharmaceutical ingredients under Section 232 of the Trade Expansion Act.
-
India's Pharma Market Expands 10.7% On GLP-1 Launch: Zydus, Glenmark Lead Large-Cap Growth
A majority of companies within Nomura's coverage universe outpaced the broader pharma market in August. Zydus Lifesciences and Glenmark Pharmaceuticals posted the strongest YoY value expansion.
-
Karnataka To Discuss New Guidelines On Online Medicine Sales, Pricing
Karnataka Health and Family Welfare Minister U.T. Khader on Monday said the state government was adopting a two-pronged approach to strengthen inspections and enforcement in the food and pharmaceutical sectors, amid complaints regarding expired medicines, mislabelling, and exorbitant prices.
-
Fake, Expired Medicines Worth Rs 5 Crore Seized Repacking Unit In Bengaluru
According to the FDA, the operators were procuring lower-cost medicines from other states and allegedly filling them into new vials before relabelling them to resemble expensive multinational and imported drug brands.
-
Eli Lilly Shares Surge 6% On Upbeat Annual Earnings Forecast; Mounjaro Sales Spike 91%
Due to expenses associated with commercial activity during the quarter, Lilly reduced the upper end of its full-year profit expectation.
-
New HIV Pill Delivers Breakthrough Results In First Human Trial
Researchers say the treatment appears safe and effective so far, although larger Phase 3 trials will be needed before it can be approved for widespread use.
-
Glenmark Pharma Q1 Results: Profit Rises Exponentially To Rs 483 Crore; Revenue Jumps 23%
Glenmark Pharmaceuticals reported a consolidated net profit of Rs 483 crore, compared with Rs 47 crore in the corresponding quarter last year.
-
One QR Scan Can Tell If Your Medicine Is Fake. Here's How It Works
The government has steadily expanded the use of QR codes to make fake medicines harder to introduce into the supply chain.
-
US Turn To Indian Pharmaceuticals Amid Critical Cancer Drug Shortage
US has sought help from Indian pharmaceutical manufacturers to address a shortage of the cancer drug ifosfamide.
